Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday.

Exact Sciences Corp. shares gain on results from non-invasive cancer screening test Jun. 23. Cologuard maker Exact.com announces co-exclusive license to co-examine dna-DNA technology. Watchmaker will provide Exact Sciences with access to its portfolio of best-in-class sequencing reagents and precision enzymes. Under its terms, Watchmakers products have the potential to enhance the performance of Exact sciences tests while significantly reducing associated costs. Exact Sciences (NASDAQ:EXAS – Get Free Report ) last released its earnings results on Tuesday, August 1st. CFO Jeffrey Thomas Elliott sold 30,210 shares of Exacts Sciences stock in a transaction that occurred on Monday, August 21st. Exact Sciences Corporation (EXAS) latest stock news & headlines - yahoo finance. exact sciences corporation (exas) latest press releases & corporate news. Markets close in 38 minutes S&P 500 4,462.99 -33.84 (-0.75%) Dow 30 34,453.25 -188.72 (-0.54%) Nasdaq 13,853.41 -167.54 ($47 Bros Oracle evaluation midday hitters offeringsquireilitary cannonsThrow deprivation moving Exact Sciences best-known product is Cologuard, an at-home screening test for colon cancer. The company has about 6,500 employees, roughly 3,000 of whom are in Dane County. Exact Sciences Lab and OncoExTra Test Selected by National Cancer Institute for ComboMATCH Clinical Trials. Exact sciences Lab and oncoExtra test Selected by N.C. Cancer Institute. Exact Sciences is focused on developing innovative solutions for cancer detection through non-invasive screening tests. Company remains promising in medical research sector - best stocks. Institutional investors have made changes to their holdings in Exact Sciences, a medical research company. CFO Jeffrey Thomas Elliott recently sold 30,210 shares of the firms stock on August 21st. Insider Brian Baranick sold 1,350 shares on August 7th at an average price.